Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - CEVEC Pharmaceuticals

July 6, 2015
CEVEC's CAP(R)Go derived recombinant placental human alkaline phosphatase shows superior results ...
New CAP(R)Go cell line for the production of glyco-optimized recombinant human alkaline phosphatase successfully established. More

November 1, 2013
Completion of a “First in Human” Clinical Phase I Study with a Therapeutic Protein Derived from ...
Completion of a “First in Human” Clinical Phase I Study with a Therapeutic Protein Derived from CAP® Cells. More

January 3, 2013
CEVEC Pharmaceuticals and Vakzine Projekt Management Sign Exclusive License Agreement
CEVEC Pharmaceuticals and Vakzine Projekt Management Sign Exclusive License Agreement on the Clinical Development of a Novel Human Cytomegalovirus (CMV) Vaccine More

November 5, 2012
CCS Cell Culture Service Signs Strategic License Agreement with CEVEC Pharmaceuticals
CEVEC Pharmaceuticals ('CEVEC'), the developer of a novel human expression system derived from amniocytes, and CCS Cell Culture Service GmbH ('CCS'), a contract research organization based in Hamburg, Germany, announced today the signing of a strategic license agreement. More

August 18, 2010
CEVEC signs global license agreement for human CAP-T technology with Life Technologies
EVEC Pharmaceuticals, the developer of a novel human protein expression system derived from amniocytes, announced today the signing of a co-exclusive worldwide licensing agreement with Life Technologies Corporation. More

December 8, 2009
Inno Biologics and CEVEC sign license agreement for human CAP technology
developer of a novel human expression system derived from amniocytes “CEVEC Pharmaceuticals” and the contract manufacturer Inno Biologics Sdn Bhd, Malaysia, announced today the signing of a strategic license agreement. More

November 3, 2009
CEVEC raises €4M to finance strong growth of human CAP technology
CEVEC Pharmaceuticals, specializing in the development of complex therapeutic proteins based on the human CAP Technology, today announced the closing of a €4M financing round. More

Data


26,416
Tech investments
From our Online Data Service
17,054
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 30€3.6MSoftware development
Nov 29€3.6MBiopharmaceuticals
Nov 28N/ABiotechnology
Nov 28N/ABusiness applications
Nov 28€12.0MPublishing
Nov 28N/AeLearning
Nov 28€7.6MSensors

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.